Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle

NCT03079401 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03079401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
Lead sponsor
Boston Children's Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 27, 2017
Completion date
January 31, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrioventricular canal, hypoplastic left heart syndrome